• Home
  • The MMS Difference
    • About Us
    • Leadership
    • Certifications
  • Services
    • Regulatory Affairs and Operations
    • Data Management and Biostatistics
    • Regulatory and Medical Writing
    • Drug Safety and Pharmacovigilance
    • Compliance and Transparency
    • Data Sciences
  • Working with MMS
  • News and Media
  • MMS Blog
  • Careers
  • Contact Us
MMS
MMS Holdings Leverages Medrio to Accelerate Clinical Trial Process for Study Sponsors Through New Contract

MMS Holdings Leverages Medrio to Accelerate Clinical Trial Process for Study Sponsors Through New Contract

by Don McLean | May 8, 2019 | News

MMS Holdings Leverages Medrio to Accelerate Clinical Trial Process for Study Sponsors Through New Contract The agreement demonstrates the value of Medrio’s support resources in facilitating mutual success for CROs and study sponsors.   SAN FRANCISCO (May 08,...
Ask the Expert: Clinical Data Management Standards, Benefits, and its Future

Ask the Expert: Clinical Data Management Standards, Benefits, and its Future

by Don McLean | Dec 6, 2018 | Blog

  Ask the Expert: Data Management Standards, Benefits, and its Future   For this edition of Expert Insights, we talk with Doreen van Huyssteen, Manager of Data Management at MMS – based in Bloemfontein, South Africa. What is the difference between CDISC and...

Recent Posts

  • Planning for Health Canada’s New Transparency Initiatives for Clinical Data
  • MMS HOLDINGS NAMED HONORABLE MENTION IN PRESTIGIOUS PR DAILY CORPORATE SOCIAL RESPONSIBILITY AWARDS FOR #ONEMMS VOLUNTEER INITIATIVE
  • Pharmaceutical Industry Experts Speak Out: Five Productivity Tips for Working from Home
  • Pharmaceutical Industry News Roundup: August 2019
  • Using Real World Data in Drug Development: Five Questions with Vijay Ivaturi, PhD

Tags

ALZ awareness Alzheimers big data biosimilars biostatistics Clinical Development clinical research clinical study reports clinical trials clinical trial transparency Community Compliance CRO data management data privacy data science drug development EMA ENDALZ FDA Flint GDPR GXP auditing Health Analytics Collective Health Canada Lay summaries leadership medical writing NDA submission News opioids pharma pharmacovigilance PhUSE Policy 0070 quality control real world data regulatory operations REMS resourcing statistical programming suicidality transparency trial regulation Volunteering